Gilead's Hepcludex wins FDA approval for chronic HDV infection
Gilead Sciences Inc · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $134.43
+1.4% in 3d after detection
Post-detection moves
1h
+0.1%
1d
-0.3%
3d
+1.4%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS